Why this board member still believes in Theranos

One Theranos board member is standing by the Palo Alto, Calif.-based blood testing startup despite the onslaught of doubts reported by the media.

Advertisement

Former Wells Fargo CEO Dick Kovacevich said Thursday on CNBC’s “Squawk Box” he still believes in the company’s technology and that there is a lot of misinformation out there. He also said more accurate information is on the way, according to CNBC.

“I think these are all normal things that happen with a startup, and there’s been excessive publicity for something that is not unusual in start-ups,” he said.

Editor’s Note: This article was updated on June 3, 2016 at 10:25 a.m. CT. It previously stated Dick Kovacevich was the CEO of Wells Fargo. He is a former CEO of Wells Fargo. We regret this error. 

More articles on leadership and management:

Is CEO pay increasing or decreasing? It depends
Can ‘front-stabbing’ cultivate a culture of happiness at work?
Rome Memorial Hospital names former CEO to board: 3 things to know

At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Leadership & Management

Advertisement

Comments are closed.